<?xml version="1.0" encoding="UTF-8"?>
<p>We also evaluated the anticancer effect of A.S. combined with conventional drugs such as axitinib and dovitinib. Tyrosine kinase inhibitors, axitinib and dovitinib, showed anticancer effects in leukemia cells [
 <xref rid="B33-molecules-26-00035" ref-type="bibr">33</xref>,
 <xref rid="B34-molecules-26-00035" ref-type="bibr">34</xref>,
 <xref rid="B35-molecules-26-00035" ref-type="bibr">35</xref>]. The combined treatment of these tyrosine kinase inhibitors with other chemotherapy exerts effective therapeutic results in leukemia [
 <xref rid="B17-molecules-26-00035" ref-type="bibr">17</xref>,
 <xref rid="B36-molecules-26-00035" ref-type="bibr">36</xref>]. The combination therapy with tyrosine kinase inhibitors such as axitinib and dovitinib may enhance the inhibitory effect of A.S. extract on Jurkat cell proliferation by decreasing PMA/PHA-mediated IL-2 secretion in this study.
</p>
